Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance.
Kita K, Fukuda K, Takahashi H, Tanimoto A, Nishiyama A, Arai S, Takeuchi S, Yamashita K, Ohtsubo K, Otani S, Yanagimura N, Suzuki C, Ikeda H, Tamura M, Matsumoto I, Yano S.
Kita K, et al. Among authors: ikeda h.
Cancer Sci. 2019 Oct;110(10):3215-3224. doi: 10.1111/cas.14171.
Cancer Sci. 2019.
PMID: 31432603
Free PMC article.